Syd Labs D-荧光素钾盐（D-Luciferin Potassium Salt）怎么配置？

Syd Labs D-荧光素钾盐怎么配置？看这些文献就懂了

Syd Labs D-荧光素钾盐（D-Luciferin Potassium Salt,CAS号:115144-35-9）怎么配置？Syd Labs D-荧光素钾盐（D-Luciferin Potassium Salt，货号MB000102-R70170或MB102-R70170），作为一项经过国际市场检验、主要用于动物体内实验的产品，在品质与成本效益上具有双重优势，这表明其在国际市场上具有较大的竞争力。Syd Labs D-荧光素钾盐（D-Luciferin Potassium Salt）现已强势登陆中国市场，期待为中国高校的动物实验中心和实验室注入新的活力。

Syd Labs D-荧光素钾盐（D-Luciferin Potassium Salt，货号：MB000102-R70170或MB102-R70170）因其卓越表现，在欧美多所知名大学的core facilities中获得高度认可，也成为了许多寻求高质量实验材料的研究人员的理想之选。Syd Labs D-荧光素钾盐（D-Luciferin Potassium Salt）的优质成效不仅体现在实际应用中，更在众多国际权威学术期刊中得以体现。Syd Labs D-荧光素钾盐（D-Luciferin Potassium Salt）被以下三篇文献引用：

33.

Influence of lipid composition of messenger RNA-loaded lipid nanoparticles on the protein expression via intratracheal administration in mice

Longjian Geng, Naoya Kato, Yukinobu Kodama, Hidefumi Mukai, Shigeru Kawakami

Int J Pharm. 2023 Apr 25:637:122896. doi: 10.1016/j.ijpharm.2023.122896. Epub 2023 Mar 25.

Six h after i.t. administration of mRNA-LNPs at a dose of 2 μg mRNA per mouse, the mice were intraperitoneally (i.p.) injected with 150 mg/kg D-luciferin (Syd Labs, Boston, MA, USA) in PBS. After 15 min, the mice were euthanised, and the liver, heart, spleen, kidney, and lungs were harvested. The obtained organs were imaged by IVIS Lumina II (Caliper Life Sciences, Hopkinton, MA, USA), with a luminescence setting and exposure time of 1 min.

34.

Biohybrid microrobots locally and actively deliver drug-loaded nanoparticles to inhibit the progression of lung metastasis

Fangyu Zhang, Zhongyuan Guo, Zhengxing Li, Hao Luan, Yiyan Yu, Audrey T Zhu, Shichao Ding, Weiwei Gao, Ronnie H Fang, Liangfang Zhang, Joseph Wang

Sci Adv. 2024 Jun 14;10(24):eadn6157. doi: 10.1126/sciadv.adn6157. Epub 2024 Jun 12.

To establish an experimental lung metastasis model, 1 × 105 B16-F10-Luc2 cells (ATCC CRL-6475-LUC2) were injected intravenously into the tail vein of female C57BL/6 mice. The mice received treatment with free DOX, NP(DOX), and algae-NP(DOX)-robot through intratracheal instillation on days 1, 3, 5, and 7 after tumor cell inoculation. Mice without treatment were used as controls. To monitor tumor growth, on days 12, 16, 20, 24, and 28 after tumor cell inoculation, the mice were intraperitoneally administered 200 μl of d-luciferin (5 mg ml−1; Syd Labs) in Dulbecco’s Phosphate-Buffered Saline (DPBS, Gibco). Bioluminescence signals were detected using a PerkinElmer Xenogen IVIS 200 system. The body weight and survival of each mouse were also monitored throughout the study. The survival endpoint was defined as either death or moribundity upon observation.

35.

Probing the effects of polysaccharide hydrogel composition on the viability and pro-angiogenic function of human adipose-derived stromal cells

Fiona E. Serack, Kaylee A. Fennell, Christina Iliopoulos, John T. Walker, John A. Ronald,Brian G. Amsden, David A. Hess, Lauren E. Flynn

bioRxiv preprint doi: https://doi.org/10.1101/2024.05.10.593603

Longitudinal in vivo bioluminescence imaging (BLI) was used to assess the retention of the viable FLuc+transduced hASCs in the ischemic limbs at days 1 (following injection), 3, 7, 14, 21, and 28. Mice were anaesthetized using isoflurane and received an intraperitoneal injection of 100 μL of 30 mg/mL D-luciferin (Syd Labs), following which they were imaged using an IVIS Lumina XRMS In Vivo Imaging System (PerkinElmer). ROIs of consistent size were drawn around the site of injection and used to quantify the average radiance (p/s/cm2/sr) of the luminescence signal.Images were taken using auto-exposure until the average radiance reached a peak value. Average radiance values were normalized to the day 1 values for each mouse.